Company Filing History:
Years Active: 2005
Title: An Insight into Inventor Michael Franti from La Garenne-Colombes, France
Introduction
Michael Franti is a notable inventor based in La Garenne-Colombes, France, who has made significant contributions to the field of biotechnology. His work specifically focuses on immunogenic peptides and their diagnostic applications, marking an important step in the medical diagnostics industry.
Latest Patents
Mr. Franti holds one patent for his invention titled "Glycoprotein peptide of the human herpesvirus-7 for use in particular in an ELISA serologic test." This innovative invention involves an immunogenic peptide consisting of at least six consecutive amino acids from a hydrophilic region of the glycoprotein B (gB) of the human herpesvirus-7 (HHV-7). This peptide is designed to react specifically with antibodies directed against HHV-7, contributing significantly to diagnosis kits that utilize it for improved identification of the virus.
Career Highlights
Michael Franti is associated with Université Pierre et Marie Curie (Paris VI), a prestigious institution recognized for its scientific research and educational programs. His work at the university has allowed him to explore and develop significant advancements in immunology and peptide synthesis.
Collaborations
Franti has collaborated with fellow researcher Henri Agut, enhancing the depth and breadth of his research endeavors. Their joint efforts have yielded impactful results in understanding herpesvirus-related diagnostics, demonstrating the power of teamwork in advancing scientific research.
Conclusion
Michael Franti's contributions to the field of biotechnology through his patented work on glycoprotein peptides highlight the importance of innovation in medical diagnostics. His affiliation with Université Pierre et Marie Curie and collaborative efforts underline a commitment to enhancing health outcomes through research and creativity in the scientific community.